Application Note: EarlyTox Cardiotoxicity Kit Provides Biologically Relevant Cardiotoxicty Data Earlier in the Drug Discovery Process
16 October 2013

Assessing cardiotoxicity is important during early stages of drug discovery to eliminate potentially toxic compounds from further development. This application note describes a cardiotoxicity kit that provides a robust, high throughput method, using a novel calcium sensitive dye and a proprietary masking technology, to measure the impact of pharmacological compounds on stem cell-derived cardiomyocytes.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions

Already a member?

Log in for full access to the article

Remember me